Reconstructing Human Exposures Using Biomarkers and other “Clues”
- 1 January 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part B
- Vol. 15 (1) , 22-38
Abstract
Biomonitoring is the process by which biomarkers are measured in human tissues and specimens to evaluate exposures. Given the growing number of population-based biomonitoring surveys, there is now an escalated interest in using biomarker data to reconstruct exposures for supporting risk assessment and risk management. While detection of biomarkers is de facto evidence of exposure and absorption, biomarker data cannot be used to reconstruct exposure unless other information is available to establish the external exposure–biomarker concentration relationship. In this review, the process of using biomarker data and other information to reconstruct human exposures is examined. Information that is essential to the exposure reconstruction process includes (1) the type of biomarker based on its origin (e.g., endogenous vs. exogenous), (2) the purpose/design of the biomonitoring study (e.g., occupational monitoring), (3) exposure information (including product/chemical use scenarios and reasons for expected contact, the physicochemical properties of the chemical and nature of the residues, and likely exposure scenarios), and (4) an understanding of the biological system and mechanisms of clearance. This review also presents the use of exposure modeling, pharmacokinetic modeling, and molecular modeling to assist in integrating these various types of information.Keywords
This publication has 40 references indexed in Scilit:
- A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouseToxicology and Applied Pharmacology, 2011
- Probabilistic Modeling of Dietary Arsenic Exposure and Dose and Evaluation with 2003–2004 NHANES DataEnvironmental Health Perspectives, 2010
- Population Physiologically Based Pharmacokinetic Modeling for the Human Lactational Transfer of PCB-153 with Consideration of Worldwide Human Biomonitoring ResultsEnvironmental Health Perspectives, 2008
- Reconstructing population exposures to environmental chemicals from biomarkers: Challenges and opportunitiesJournal of Exposure Science & Environmental Epidemiology, 2008
- Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approachesToxicology, 2007
- Assessing Exposure to Atrazine and Its Metabolites Using BiomonitoringEnvironmental Health Perspectives, 2007
- Use of Markov Chain Monte Carlo Analysis with a Physiologically‐Based Pharmacokinetic Model of Methylmercury to Estimate Exposures in U.S. Women of Childbearing AgeRisk Analysis, 2007
- Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for ChloroformJournal of Toxicology and Environmental Health, Part A, 2006
- Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case studyJournal of Exposure Science & Environmental Epidemiology, 2004
- Exposure Measurement Needs for Hazardous Waste Sites: Two Case StudiesToxicology and Industrial Health, 1996